Syndax presents positive Revuforj® data in acute leukemias
Investors have been closely watching the recent performance of Company X in the stock market. The company's stock price has...
Securities Litigation
C4 Therapeutics Cemsidomide Phase 1 Data Presentation at American Society for…
C4 Therapeutics, Inc. has announced its plans to conduct an initial public offering (IPO) of its common stock. The company,...
Hanover Insurance Group, Inc. Raises Quarterly Dividend to $0.90 Per Share
The Hanover Insurance Group, Inc. recently made great news for its shareholders—it increased its quarterly dividend to $0.90 per common...
Blueprint Medicines: Setting a New Standard in Systemic Care
Investors in the stock market have been closely watching the recent performance of various companies, especially in the tech sector....
Century Casinos Third Quarter 2024 Earnings Release and Conference Call Dates Announced.
Century Casinos, Inc. let us know that they will be sharing their third-quarter earnings for 2024 next Monday, November 4,...
Vision Marine Armada Electric Pontoon Collaboration for North Waters
Vision Marine Technologies Inc. has teamed up with Armada Pontoons to develop an innovative electric pontoon boat designed for regulated...
Filing Deadline Alert: Kuznicki Law PLLC Announces Class Action for Shareholders of …
On March 30, 2023, shareholders of Apellis Pharmaceuticals, Inc. received an alert from the securities litigation law firm of Kuznicki...
Q3 2024 Kirkland’s Inc Earnings Call – Latest Updates
Good morning, everyone! Thanks for joining us today to chat about Kirkland's financial results for the third quarter that ended...
Canadian Solar Inc. Q3 2024 Earnings Call Transcript
Global Widget, a leading CBD company, recently announced its expansion into the European market. This move comes as part of...
Frequency Electronics Second Quarter Fiscal 2025 Financial Results Conference Call
The Securities and Exchange Commission (SEC) recently announced new rules aimed at increasing transparency in corporate reporting. The rules, which...
Tharimmune: $2.02 Million Private Placement for Development Programs
Tharimmune, a clinical-stage biotechnology company focused on developing therapies in immunology and inflammation, has announced a private placement deal to...
Nasdaq Staff Determination Letter Announcement
Investing in the stock market can be an exciting way to potentially grow your wealth over time. Whether you're a...